for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Karuna Therapeutics Inc

KRTX.O

Latest Trade

99.75USD

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

11.24

 - 

152.00

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
99.75
Open
--
Volume
--
3M AVG Volume
18.20
Today's High
--
Today's Low
--
52 Week High
152.00
52 Week Low
11.24
Shares Out (MIL)
26.01
Market Cap (MIL)
2,594.77
Forward P/E
--
Dividend (Yield %)
--

Latest Developments

More

Puretech Health Reported A Stake Of 20.4% In Karuna Therapeutics

Karuna Therapeutics Announces Pricing Of $250 Million Public Offering Of Common Stock

Karuna Therapeutics Files For Offering Of Up To 2.6 Mln Shares Of Common Stock - SEC Filing

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Karuna Therapeutics Inc

Karuna Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies to address disabling neuropsychiatric conditions. Its lead product candidate, KarXT, is an oral modulator of muscarinic receptors that are located both in the central nervous system (CNS) and various peripheral tissues. It is initially developing KarXT, for the treatment of acute psychosis in patients with schizophrenia. The Company is developing a pipeline of therapeutic programs to address symptoms associated with schizophrenia and psychosis associated with Alzheimer’s disease (AD), as well as various forms of pain. KarXT is a combination of xanomeline and trospium.

Contact Info

33 Arch St Ste 3110

+1.857.4492244

https://karunatx.com/

Executive Leadership

Steven M. Paul

Chairman of the Board, Chief Executive Officer

Andrew Craig Miller

Founder, Chief Operating Officer

Troy A. Ignelzi

Chief Financial Officer

Giorgio Attardo

Vice President, CMC and Preclinical Development

Stephen K Brannan

Chief Medical Officer

Key Stats

1.43 mean rating - 7 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2019(E)

0.0K
EPS (USD)

2019(E)

-2.589
Price To Earnings (TTM)
--
Price To Sales (TTM)
--
Price To Book (MRQ)
14.37
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
0.00
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
--
Return on Equity (TTM)
--

Latest News

Latest News

IFR US ECM Weekly Wrap-up

WEEKLY TOTAL $9.6bn – IPO $993m – ABB/BLOCK $6.3bn – FOLLOW-ON $1.65bn – CB $705m Monday

IFR US ECM Calendar

Canaan (China, cryptocurrency) – $90m IPO. 10m ADSs (100% prim) at $9.00 versus $9-$11 marketing. CITI, CREN, CMBI. Nasdaq "CAN". 14 investors indicated an interest in 5% of the ADSs.

IFR US ECM Calendar

Canaan (China, cryptocurrency) – $90m IPO. 10m ADSs (100% prim) at $9.00 versus $9-$11 marketing. CITI, CREN, CMBI. Nasdaq "CAN". 14 investors indicated an interest in 5% of the ADSs.

IFR US ECM Calendar

Amplitude Healthcare Acquisition (US, SPAC) – $100m IPO. 10m units (100% prim) at $10.00. Each unit comprises one share and one-half of a warrant. BMO, SVBL.

IFR US ECM Calendar

Amplitude Healthcare Acquisition (US, SPAC) – $100m IPO. 10m units (100% prim) at $10.00. Each unit comprises one share and one-half of a warrant. BMO, SVBL.

FTSE up for third day on China stimulus hopes, Halma jump

London's FTSE 100 shed most of its earlier gains but still managed to close higher on Tuesday, as sentiment was supported by a surge in safety equipment maker Halma and hopes of more stimulus from economic powerhouse China.

IFR US ECM Calendar

8X8 (US, software)– $75m add-on to 0.5% CB due 2024. MS. Add-on to $287.5m principal 0.5% notes due 2024.

UPDATE 2-IFR US ECM Calendar

Canadian Apartment Properties REIT (Canada, REIT) – C$350m Block. 6.5m units (100% prim) at C$53.60 versus C$55.85 last sale. RBC.

IFR US ECM Calendar

November 18: GreenVision Acquisition (China, SPAC) – $50m IPO. 5m units (100% prim) at $10.00. Each unit comprises one share and one full warrant. IBANK.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up